Trump administration imposes 100 percent tariff on patented drug imports

The Trump administration imposed a 100 percent tariff on imports of patented drugs, effective Thursday. Australian biotech firm CSL will be exempt, as tariffs will be reduced to zero for plasma-derived therapies. The move aims to re-shore pharmaceutical production in the U.S. and lower drug prices for American consumers.

Read more on SMH →